Indonesia · Delayed Price · Currency is IDR Ligand Pharmaceuticals Statistics
Total Valuation
IDX:RMKE has a market cap or net worth of IDR 2.65 trillion. The enterprise value is 2.94 trillion.
| Market Cap | 2.65T |
| Enterprise Value | 2.94T |
Important Dates
The last earnings date was Friday, August 1, 2025.
| Earnings Date | Aug 1, 2025 |
| Ex-Dividend Date | Jun 26, 2025 |
Share Statistics
IDX:RMKE has 4.38 billion shares outstanding.
| Current Share Class | 4.38B |
| Shares Outstanding | 4.38B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 3.20% |
| Owned by Institutions (%) | 0.08% |
| Float | 875.00M |
Valuation Ratios
The trailing PE ratio is 10.67.
| PE Ratio | 10.67 |
| Forward PE | n/a |
| PS Ratio | 1.47 |
| PB Ratio | 1.47 |
| P/TBV Ratio | 1.48 |
| P/FCF Ratio | 15.96 |
| P/OCF Ratio | 7.81 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.86, with an EV/FCF ratio of 17.70.
| EV / Earnings | 11.84 |
| EV / Sales | 1.63 |
| EV / EBITDA | 7.86 |
| EV / EBIT | 8.80 |
| EV / FCF | 17.70 |
Financial Position
The company has a current ratio of 2.34, with a Debt / Equity ratio of 0.16.
| Current Ratio | 2.34 |
| Quick Ratio | 1.27 |
| Debt / Equity | 0.16 |
| Debt / EBITDA | 0.79 |
| Debt / FCF | 1.77 |
| Interest Coverage | 11.09 |
Financial Efficiency
Return on equity (ROE) is 14.78% and return on invested capital (ROIC) is 10.17%.
| Return on Equity (ROE) | 14.78% |
| Return on Assets (ROA) | 9.13% |
| Return on Invested Capital (ROIC) | 10.17% |
| Return on Capital Employed (ROCE) | 18.03% |
| Revenue Per Employee | 2.10B |
| Profits Per Employee | 289.74M |
| Employee Count | 1,160 |
| Asset Turnover | 0.79 |
| Inventory Turnover | 6.87 |
Taxes
In the past 12 months, IDX:RMKE has paid 74.74 billion in taxes.
| Income Tax | 74.74B |
| Effective Tax Rate | 23.10% |
Stock Price Statistics
The stock price has increased by +7.08% in the last 52 weeks. The beta is -0.04, so IDX:RMKE's price volatility has been lower than the market average.
| Beta (5Y) | -0.04 |
| 52-Week Price Change | +7.08% |
| 50-Day Moving Average | 522.60 |
| 200-Day Moving Average | 523.65 |
| Relative Strength Index (RSI) | 84.52 |
| Average Volume (20 Days) | 2,248,845 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IDX:RMKE had revenue of IDR 1.80 trillion and earned 248.02 billion in profits. Earnings per share was 56.69.
| Revenue | 1.80T |
| Gross Profit | 414.50B |
| Operating Income | 334.70B |
| Pretax Income | 323.56B |
| Net Income | 248.02B |
| EBITDA | 373.99B |
| EBIT | 334.70B |
| Earnings Per Share (EPS) | 56.69 |
Balance Sheet
The company has 15.22 billion in cash and 294.30 billion in debt, giving a net cash position of -279.08 billion or -63.79 per share.
| Cash & Cash Equivalents | 15.22B |
| Total Debt | 294.30B |
| Net Cash | -279.08B |
| Net Cash Per Share | -63.79 |
| Equity (Book Value) | 1.80T |
| Book Value Per Share | 409.01 |
| Working Capital | 602.75B |
Cash Flow
In the last 12 months, operating cash flow was 339.09 billion and capital expenditures -173.26 billion, giving a free cash flow of 165.84 billion.
| Operating Cash Flow | 339.09B |
| Capital Expenditures | -173.26B |
| Free Cash Flow | 165.84B |
| FCF Per Share | 37.91 |
Margins
Gross margin is 23.05%, with operating and profit margins of 18.61% and 13.79%.
| Gross Margin | 23.05% |
| Operating Margin | 18.61% |
| Pretax Margin | 17.99% |
| Profit Margin | 13.79% |
| EBITDA Margin | 20.79% |
| EBIT Margin | 18.61% |
| FCF Margin | 9.22% |
Dividends & Yields
This stock pays an annual dividend of 7.00, which amounts to a dividend yield of 1.16%.
| Dividend Per Share | 7.00 |
| Dividend Yield | 1.16% |
| Dividend Growth (YoY) | -50.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 12.35% |
| Buyback Yield | n/a |
| Shareholder Yield | 1.18% |
| Earnings Yield | 9.37% |
| FCF Yield | 6.27% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IDX:RMKE has an Altman Z-Score of 5.13 and a Piotroski F-Score of 7.
| Altman Z-Score | 5.13 |
| Piotroski F-Score | 7 |